New study investigates why some AML patients face early bleeding or clotting risks

This observational study examines a specific group of patients with a type of acute myeloid leukemia (AML) that has an NPM1 mutation. Researchers want to see if a particular subset, called APL-like, is linked to early blood vessel problems like bleeding or clots. The study will look back at past cases and also follow new patients to better understand this connection. It does not test any new treatment, but aims to improve knowledge about this disease.